NRSNW NASDAQ

NeuroSense Therapeutics Ltd. - Warrant

$0.21
▲ +$0.00 (+0.00%)

Price Chart

Quarterly Revenue & Earnings

Quarter 2024-0… 2024-0… 2024-1…
Revenue
Net Income -$857K -$2.1M -$1.8M

Financial Health

Cash
$666K
As of Jun 30, 2025

Top Holders

Top 5: 8.93%
Empery Asset Management, LP
5.44%
$20K
Clear Street Group Inc.
3.43%
$13K
UBS Group AG
0.06%
$232
As of Dec 31, 2025

Latest News

No related news yet